As binx prepares for the next phase of expansion, it welcomes Life Sciences veteran Jack Crowley to the leadership team as Chief Financial Officer.
Fremont, CA:“We are thrilled to welcome Jack to our leadership team,” states Jeff Luber, binx CEO. Jack Crowley has been appointed Chief Financial Officer of binx health, a healthcare technology, and diagnostics company. Crowley has extensive life sciences sector expertise and a track record of successful initial and secondary public offerings, capital structure modifications, analyst engagement, and investor relations.
“Whether at PricewaterhouseCoopers, Thermofisher Scientific, Biogen, Lantheus Medical Imaging, or PGDx, Jack has consistently demonstrated the ability to build great finance teams, lead in high-growth environments, and deliver on commitments, quarter after quarter. It’s these talents, and his clear sense of purpose, that will help us in delivering on our vision of ‘everywhere care’”. Adds Jeff.
Crowley was previously the Chief Financial Officer of Ora, Inc, a global leader in full-service ophthalmic research. Jack has also worked as Chief Financial Officer of Personal Genome Diagnostics and Lantheus Medical Imaging, as well as holding senior financial positions at Biogen, Thermofisher Scientific, and PricewaterhouseCoopers. Crowley holds a CPA and an MBA from the University of Massachusetts and Westfield State University, respectively. Crowley has established a reputation as a results-driven finance leader throughout his career, working for Fortune 500 and private equity-backed organizations.
"binx health has a vision for healthcare delivery that addresses current gaps in healthcare equity and healthcare access," comments Jack Crowley. "This is a unique and transformational approach. I am appreciative of the opportunity and excited to work with this strong team to help realize this vision and expand upon it."